Flatten the COVID-19 curve

Article

The White House announced an ambitious 15-day plan to slow the spread of COVID-19 across the United States.

Yesterday afternoon the White House held a press conference and unveiled a 15-day plan with the aim to slow the spread of COVID-19 across the United States and attempt to keep the health care system from being overwhelmed.

The plan calls for limiting social gatherings to no more than 10 people; quarantining members of the household who test positive for the disease; and closing places where people usually congregate and restricting other communal gatherings. Those persons who have underlying health conditions should stay away from other people and working or schooling from home should occur, if possible.

During the press conference, Deborah Birx, MD, a top HIV/AIDS official and one of the more visible members of the coronavirus task force, said, "The reason we’re taking these strong and bold steps is because we know there is virus spread before you develop symptoms, and then we know that there’s a large group-we don’t know the precise percent yet-that actually is asymptomatic or has such mild cases that they continue to spread the virus."

The task force stressed that members of the public should not consider the 15th day as the end of the plan and return to normal life.

 

For more details on the plan, check out the full article from our sister publication, Managed Healthcare Executive.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Related Content
© 2025 MJH Life Sciences

All rights reserved.